PYC vs TRI

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

PYC

PYC THERAP FPO [PYC]

41LOW

TRI

TRIVARX FPO [TRI]

41LOW

Score Breakdown

PYC TRI
Technical
33
44
Catalyst
50
50
Sentiment
50
50
Fundamental
34
45
Momentum
54
67
Risk Gate
50
35

Key Metrics

PYC Metric TRI
$1.1BMarket Cap$19.6M
1.8MAvg Volume (20d)1.2M
+0.1%Short Interest+0.0%
$1.75552-Week High$0.035
$0.84752-Week Low$0.007
+3.0%Daily Change+0.0%
$1.215Entry Price$0.017
-47.5%ROE-12.1%
-231.3%Profit MarginN/A

Active Signals

PYC Signals

●RSI is looking oversold — historically a spot where stocks tend to bounce
●Trading below both moving averages — the trend is working against this one
●Took a hit — down 11.0% over the last 5 days
●Volatility is expanding fast — choppy price action, so buckle up
●Below the 200-day average — the long-term trend is still working against it
●Adequate cash runway (7 quarters)
●Very high P/S ratio (54.9x)
●Revenue in sharp decline (-25%)

TRI Signals

●RSI drifting toward oversold territory — worth watching
●Stochastic is deep in oversold territory — bounce conditions forming
●Trading below both moving averages — the trend is working against this one
●Volume surging at 3.3x normal while price falls — heavy selling pressure
●Took a hit — down 10.5% over the last 5 days
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Strong cash runway (13 quarters)
●4C filed 2026-01-29

Ask Scout AI to compare PYC and TRI in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
PYC Full Analysis → TRI Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).